Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jaime Morales Arias"'
Autor:
Lauren C. Bylsma, Anne Gulbech Ording, Adam Rosenthal, Buket Öztürk, Jon P. Fryzek, Jaime Morales Arias, Alexander Röth, Sigbjørn Berentsen
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 2980-2985 (2019)
Abstract: Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia with limited epidemiological and clinical data. We used the Danish National Patient Registries to examine CAD occurrence and risk of thromboembolic events (TEs) and
Externí odkaz:
https://doaj.org/article/16137741f18f4030a009c7a79fde986c
Autor:
Hanny Al‐Samkari, Rachael F. Grace, Andreas Glenthøj, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H. M. Kuo, D. Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales‐Arias, Keely S. Gilroy, John B. Porter, Eduard J. van Beers
Publikováno v:
American journal of hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb1244825d221f98f5fc68126c234deb
https://pubmed.ncbi.nlm.nih.gov/36594181
https://pubmed.ncbi.nlm.nih.gov/36594181
Autor:
Hanny Al-Samkari, Rachael F. Grace, Eduard J. van Beers, Feng Tai, Jaime Morales-Arias, Vanessa Beynon, Andreas Glenthøj
Publikováno v:
Blood. 140:8159-8160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b49a9bc825e8c4486e85718645e46d
https://doi.org/10.1182/blood-2022-167147
https://doi.org/10.1182/blood-2022-167147
Autor:
Alexander Röth, Wilma Barcellini, Tor Henrik Anderson Tvedt, Yoshitaka Miyakawa, David J. Kuter, Jun Su, Xiaoyu Jiang, William Hobbs, Jaime Morales Arias, Frank Shafer, Ilene C. Weitz
Patients with cold agglutinin disease (CAD) experience fatigue and poor quality of life. However, previous CAD-related studies have not explored patient-reported outcomes such as the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765abaaee985525682c95cef71673071
https://www.ncbi.nlm.nih.gov/pubmed/35999387
https://www.ncbi.nlm.nih.gov/pubmed/35999387
Autor:
Jaime Morales Arias, Parija Patel, Alexander Röth, Catherine Broome, Jun Su, Heidi Reichert, Jon P. Fryzek, Xiaohui Jiang
Publikováno v:
TransfusionREFERENCES. 62(1)
Background: Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia mediated by immunoglobulin M autoantibodies that bind to the “I” antigen on erythrocytes. IgM binding results in either agglutination at ≤37°C, activation of the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b572e2b2f1fdce7d89eaf3ecec75ca
https://pubmed.ncbi.nlm.nih.gov/35531960
https://pubmed.ncbi.nlm.nih.gov/35531960
Autor:
Yoshitaka Miyakawa, Bernd Jilma, Shirley D'Sa, Catherine Broome, Xiaoyu Jiang, Tor Henrik Anderson Tvedt, Joachim Fruebis, Wilma Barcellini, Stella Lin, Alexander Röth, Sigbjørn Berentsen, Jaime Morales-Arias, David J. Kuter, Marc Michel, Caroline Reuter, William Hobbs
Publikováno v:
The New England journal of medicine. 384(14)
Cold agglutinin disease is a rare autoimmune hemolytic anemia characterized by hemolysis that is caused by activation of the classic complement pathway. Sutimlimab, a humanized monoclonal antibody, selectively targets the C1s protein, a C1 complex se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a702164368e9867e94bab8aa83edb1b1
https://pubmed.ncbi.nlm.nih.gov/33826820
https://pubmed.ncbi.nlm.nih.gov/33826820
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea476aca714c657738a3e5599ce60e36
Autor:
Alexander Röth, David J. Kuter, W. Hobbs, T.H.A. Tvedt, Jaime Morales Arias, W. Barcellini, I.C. Weitz, J. Su, Y. Miyakawa, X. Jiang, M.M.O. Barros
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 57-58 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6a398fe8c8030a3f8a21eb838b7df1
http://www.sciencedirect.com/science/article/pii/S2531137920303813
http://www.sciencedirect.com/science/article/pii/S2531137920303813
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 93-94 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55128c9a9c99943b6249180c957beceb
http://www.sciencedirect.com/science/article/pii/S2531137920304442
http://www.sciencedirect.com/science/article/pii/S2531137920304442
Autor:
Anne Gulbech Ording, Lauren C. Bylsma, Adam Rosenthal, Jon P. Fryzek, Buket Öztürk, Alexander Röth, Sigbjørn Berentsen, Jaime Morales Arias
Publikováno v:
Bylsma, L C, Ording, A G, Rosenthal, A, Öztürk, B, Fryzek, J P, Arias, J M, Röth, A & Berentsen, S 2019, ' Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease ', Blood Advances, vol. 3, no. 20, pp. 2980-2985 . https://doi.org/10.1182/bloodadvances.2019000476
Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia with limited epidemiological and clinical data. We used the Danish National Patient Registries to examine CAD occurrence and risk of thromboembolic events (TEs) and mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c69b5f89f242002f3fc96f485dadbca
https://pubmed.ncbi.nlm.nih.gov/31648316
https://pubmed.ncbi.nlm.nih.gov/31648316